Oberroth, Germany

Hans Koll

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Oberroth, DE (2008 - 2016)
  • Schwabhausen, DE (2019)

Company Filing History:


Years Active: 2008-2019

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Hans Koll

Introduction

Hans Koll is a notable inventor based in Oberroth, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of analytical methods and antibody preparations. With a total of 7 patents to his name, Koll's work has advanced the understanding and application of antibodies in medical diagnostics and therapeutics.

Latest Patents

Koll's latest patents include groundbreaking inventions such as a method for A-fucosylation detection in antibodies. This invention describes a new analytical method to determine the quantity and distribution of fucose per Fc within an antibody preparation. Another significant patent involves antibodies against amyloid beta 4 with glycosylation in the variable region. This invention relates to a purified antibody molecule preparation characterized by at least one antigen binding site that comprises a glycosylated asparagine (Asn) in the variable region of the heavy chain. The invention provides pharmaceutical and diagnostic compositions capable of specifically recognizing the β-A4 peptide/Aβ4. These antibody isoforms may be utilized in the pharmaceutical intervention of amyloidogenesis or amyloid-plaque formation and in the diagnosis of related conditions.

Career Highlights

Throughout his career, Hans Koll has worked with prominent companies in the biotechnology sector, including Maxygen, Inc. and Roche Palo Alto LLC. His experience in these organizations has contributed to his expertise in antibody research and development.

Collaborations

Koll has collaborated with notable colleagues such as Andreas Schaubmar and Phillip A Patten. These partnerships have likely enhanced his research capabilities and led to innovative solutions in the field.

Conclusion

Hans Koll's contributions to biotechnology through his patents and collaborations have significantly impacted the development of antibody-based diagnostics and therapeutics. His innovative work continues to pave the way for advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…